|
1
|
Gustafson B: Adipose tissue, inflammation
and atherosclerosis. J Atheroscler Thromb. 17:332–341. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donath MY, Storling J, Berchtold LA,
Billestrup N and Mandrup-Poulsen T: Cytokines and beta-cell
biology: From concept to clinical translation. Endocr Rev.
29:334–350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berk BC, Weintraub WS and Alexander RW:
Elevation of C-reactive protein in ‘active’ coronary artery
disease. Am J Cardiol. 65:168–172. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ridker PM, Cushman M, Stampfer MJ, Tracy
RP and Hennekens CH: Inflammation, aspirin and the risk of
cardiovascular disease in apparently healthy men. N Engl J Med.
336:973–979. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inzucchi SE, Bergenstal RM, Buse JB,
Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R,
Matthews DR, et al: Management of hyperglycemia in type 2 diabetes:
A patient-centered approach: Position statement of the American
Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD). Diabetes Care. 35:1364–1379. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yerlikaya O, Acu M and Kinik O: Importance
of dairy products in cardiovascular diseases and type 2 diabetes.
Crit Rev Food Sci Nutr. 53:902–908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stoffers DA: The development of beta-cell
mass: Recent progress and potential role of GLP-1. Horm Metab Res.
36:811–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tourrel C, Bailbe D, Lacorne M, Meile MJ,
Kergoat M and Portha B: Persistent improvement of type 2 diabetes
in the Goto-Kakizaki rat model by expansion of the beta-cell mass
during the prediabetic period with glucagon-like peptide-1 or
exendin-4. Diabetes. 51:1443–1452. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakuraba H, Mizukami H, Yagihashi N, Wada
R, Hanyu C and Yagihashi S: Reduced beta-cell mass and expression
of oxidative stress-related DNA damage in the islet of Japanese
Type II diabetic patients. Diabetologia. 45:85–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marchetti P, Del Guerra S, Marselli L,
Lupi R, Masini M, Pollera M, Bugliani M, Boggi U, Vistoli F, Mosca
F and Del Prato S: Pancreatic islets from type 2 diabetic patients
have functional defects and increased apoptosis that are
ameliorated by metformin. J Clin Endocrinol Metab. 89:5535–5541.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cozar-Castellano I, Fiaschi-Taesch N,
Bigatel TA, Takane KK, Garcia-Ocaña A, Vasavada R and Stewart AF:
Molecular control of cell cycle progression in the pancreatic
beta-cell. Endocr Rev. 27:356–370. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jablecka A, Bogdanski P, Balcer N,
Cieslewicz A, Skoluda A and Musialik K: The effect of oral
L-arginine supplementation on fasting glucose, HbA1c, nitric oxide
and total antioxidant status in diabetic patients with
atherosclerotic peripheral arterial disease of lower extremities.
Eur Rev Med Pharmacol Sci. 16:342–350. 2012.PubMed/NCBI
|
|
13
|
Hollink IH, van den Heuvel-Eibrink MM,
Arentsen-Peters ST, Pratcorona M, Abbas S, Kuipers JE, van Galen
JF, Beverloo HB, Sonneveld E, Kaspers GJ, et al: NUP98/NSD1
characterizes a novel poor prognostic group in acute myeloid
leukemia with a distinct HOX gene expression pattern. Blood.
118:3645–3656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Trojer P, Xu CF, Cheung P, Kuo A,
Drury WJ III, Qiao Q, Neubert TA, Xu RM, Gozani O and Reinberg D:
The target of the NSD family of histone lysine methyltransferases
depends on the nature of the substrate. J Biol Chem.
284:34283–34295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morishita M, Mevius D and di Luccio E: In
vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and
NSD3/WHSC1L. BMC Struct Biol. 14:252014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Colak H, Uzgur R, Tan E, Hamidi MM, Turkal
M and Colak T: Investigation of prevalence and characteristics of
mesiodens in a non-syndromic 11256 dental outpatients. Eur Rev Med
Pharmacol Sci. 17:2684–2689. 2013.PubMed/NCBI
|
|
17
|
Hudlebusch HR, Skotte J, Santoni-Rugiu E,
Zimling ZG, Lees MJ, Simon R, Sauter G, Rota R, De Ioris MA, Quarto
M, et al: MMSET is highly expressed and associated with
aggressiveness in neuroblastoma. Cancer Res. 71:4226–4235. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toyokawa G, Cho HS, Masuda K, Yamane Y,
Yoshimatsu M, Hayami S, Takawa M, Iwai Y, Daigo Y, Tsuchiya E, et
al: Histone lysine methyltransferase Wolf-Hirschhorn syndrome
candidate 1 is involved in human carcinogenesis through regulation
of the Wnt pathway. Neoplasia. 13:887–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hudlebusch HR, Santoni-Rugiu E, Simon R,
Ralfkiær E, Rossing HH, Johansen JV, Jørgensen M, Sauter G and
Helin K: The histone methyltransferase and putative oncoprotein
MMSET is overexpressed in a large variety of human tumors. Clin
Cancer Res. 17:2919–2933. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou P, Wu LL, Wu KM, Jiang W, Li JD, Zhou
LD, Li XY, Chang S, Huang Y, Tan H, et al: Overexpression of MMSET
is correlation with poor prognosis in hepatocellular carcinoma.
Pathol Oncol Res. 19:303–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang S, Zhang Y, Meng F, Liu Y, Xia B,
Xiao M, Xu Y, Ning X, Li H and Lou G: Overexpression of multiple
myeloma SET domain (MMSET) is associated with advanced tumor
aggressiveness and poor prognosis in serous ovarian carcinoma.
Biomarkers. 18:257–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang P, Guo L, Duan ZJ, Tepper CG, Xue L,
Chen X, Kung HJ, Gao AC, Zou JX and Chen HW: Histone
methyltransferase NSD2/MMSET mediates constitutive NF-kappaB
signaling for cancer cell proliferation, survival and tumor growth
via a feed-forward loop. Mol Cell Biol. 32:3121–3131. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ezponda T, Popovic R, Shah MY,
Martinez-Garcia E, Zheng Y, Min DJ, Will C, Neri A, Kelleher NL, Yu
J and Licht JD: The histone methyltransferase MMSET/WHSC1 activates
TWIST1 to promote an epithelial-mesenchymal transition and invasive
properties of prostate cancer. Oncogene. 32:2882–2890. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Asangani IA, Ateeq B, Cao Q, Dodson L,
Pandhi M, Kunju LP, Mehra R, Lonigro RJ, Siddiqui J, Palanisamy N,
et al: Characterization of the EZH2-MMSET histone methyltransferase
regulatory axis in cancer. Mol Cell. 49:80–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M,
Lauring J, Xi Y, Park BH, Shi X, Garcia BA, et al: NSD2 links
dimethylation of histone H3 at lysine 36 to oncogenic programming.
Mol Cell. 44:609–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lauring J, Abukhdeir AM, Konishi H, Garay
JP, Gustin JP, Wang Q, Arceci RJ, Matsui W and Park BH: The
multiple myeloma associated MMSET gene contributes to cellular
adhesion, clonogenic growth and tumorigenicity. Blood. 111:856–864.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brito JL, Walker B, Jenner M, Dickens NJ,
Brown NJ, Ross FM, Avramidou A, Irving JA, Gonzalez D, Davies FE
and Morgan GJ: MMSET deregulation affects cell cycle progression
and adhesion regulons in t(4;14) myeloma plasma cells.
Haematologica. 94:78–86. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Martinez-Garcia E, Popovic R, Min DJ,
Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L and
Staudt LM: The MMSET histone methyl transferase switches global
histone methylation and alters gene expression in t(4;14) multiple
myeloma cells. Blood. 117:211–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jaffe JD, Wang Y, Chan HM, Zhang J,
Huether R, Kryukov GV, Bhang HE, Taylor JE, Hu M, Englund NP, et
al: Global chromatin profiling reveals NSD2 mutations in pediatric
acute lymphoblastic leukemia. Nat Genet. 45:1386–1391. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Duan Z, Nugent Z, Zou JX, Borowsky
AD, Zhang Y, Tepper CG, Li JJ, Fiehn O, Xu J, et al: Reprogramming
metabolism by histone methyltransferase NSD2 drives endocrine
resistance via coordinated activation of pentose phosphate pathway
enzymes. Cancer Lett. 378:69–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fujitani Y: Transcriptional regulation of
pancreas development and β-cell function [Review]. Endocr J.
64:477–486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Spaeth JM, Gupte M, Perelis M, Yang YP,
Cyphert H, Guo S, Liu JH, Guo M, Bass J, Magnuson MA, et al:
Defining a novel role for the PDX1 transcription factor in islet
beta cell maturation and proliferation during weaning. Diabetes.
66:2830–2839. 2017. View Article : Google Scholar : PubMed/NCBI
|
